Monthly Archives: July 2009

Caraco Pharma Eliminates 350 Jobs

Caraco Pharmaceutical Labs announced on Monday that it will eliminate half its workforce—approximately 350 positions—but added that the number could grow as the generics firm deals with a voluntary manufacturing shutdown stemming from an FDA investigation. Last month, US marshalls seized an undisclosed amount of drug ingredients and products in a raid at the company’s […]
Posted in Strategy | Tagged , , , , , , , , | 1 Comment

Playing Spot the Healthcare Lobbyist

National Public Radio has posted an interesting, possibly provocative, but certainly confusing, item on its website. It’s a photograph taken late last month during the first Congressional hearings on the trillion-dollar healthcare reform legislation. Actually, it’s not just a photograph but a panoramic, four-frame, interactive feature complete with cutesy rollover icons. More importantly, it shows […]
Posted in Regulatory | Tagged , , , | 2 Comments

Chantix and Zyban Get Boxed Warnings

Image via Wikipedia FDA announced yesterday afternoon that the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion) must bear black box warnings for serious mental health symptoms, including changes in behavior, hostility, depression, and attempted suicide. In addition to being used in smoking cessation, buproprion is also marketed as an atypical antidepressant under the brand […]
Posted in Strategy | Tagged , , , , , , , | 6 Comments

FDA Panel Calls for Ban on Narcotic/Tylenol Combo Drugs

Image via Wikipedia A joint committee of three FDA advisory groups voted on Tuesday to recommend the elimination of prescription combination drugs containing acetaminophen due to a spike in instances of liver-induced toxicity. The panel of experts, physicians, and regulators voted 20 to 17 in favor of banning acetaminophen combo drugs such as Vicodin and […]
Posted in Regulatory, Safety | Tagged , , , , , , , , , , , | 1 Comment
  • Categories

  • Meta